1. Home
  2. KEEL vs KARD Comparison

KEEL vs KARD Comparison

Compare KEEL & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keel Infrastructure Corp. Common Stock

KEEL

Keel Infrastructure Corp. Common Stock

N/A

Current Price

$3.42

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$14.11

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KEEL
KARD
Founded
2017
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
KEEL
KARD
Price
$3.42
$14.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
4
Target Price
$6.55
★ $42.25
AVG Volume (30 Days)
★ 25.0M
500.6K
Earning Date
11-12-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $229,276,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 72.03
N/A
52 Week Low
$2.96
$13.75
52 Week High
$7.37
$27.00

Technical Indicators

Market Signals
Indicator
KEEL
KARD
Relative Strength Index (RSI) 44.85 32.59
Support Level $3.09 $13.75
Resistance Level $3.91 $22.81
Average True Range (ATR) 0.21 1.22
MACD -0.01 -0.15
Stochastic Oscillator 24.75 21.59

Price Performance

Historical Comparison
KEEL
KARD

About KEEL Keel Infrastructure Corp. Common Stock

Keel Infrastructure Corp is a North American digital infrastructure and energy company that develops and owns data centers and energy infrastructure for high-performance computing workloads, including AI. The group has a pipeline of 2.2 gigawatts and established grid interconnections already in place. It delivers scalable infrastructure solutions in high-demand power markets across Pennsylvania and Washington in the United States, and Quebec in Canada. It has data campuses in Moses Lake, Panther Creek, Sharon, Sherbrooke, and Scrubgrass.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: